Jingzhong Guo is an accomplished analytical scientist with extensive experience in biopharmaceutical development and analytical method validation. Currently serving as Team Lead and Principal Scientist at US Pharmacopeia since June 2017, Jingzhong oversees the development and validation of analytical methods for biological reference standards and provides scientific leadership in laboratory procedures. Prior roles include Senior Scientist at Solid Biosciences, where focus was on analytical development for AAV gene therapy products, and Senior Scientist at NOVAVAX INC, specializing in mass spectrometry for vaccine characterization. Jingzhong also held positions at Boehringer Ingelheim, MethylGene Inc., and York University, contributing expertise in bioanalytical methods and mass spectrometry. Educational background includes a Post-Doc in Physical Chemistry from York University and a Ph.D. in Physical Chemistry from Shandong University.